Skip to Main Content
All Podcasts

Cancer Care in the Community

Transcript

  • 00:00 --> 00:02Support for Yale Cancer Answers
  • 00:02 --> 00:04comes from AstraZeneca, dedicated
  • 00:05 --> 00:07to advancing options and providing
  • 00:07 --> 00:10hope for people living with cancer.
  • 00:10 --> 00:14More information at astrazeneca-us.com.
  • 00:14 --> 00:15Welcome to Yale Cancer Answers
  • 00:15 --> 00:17with your host doctor Anees Chagpar.
  • 00:17 --> 00:19Yale Cancer Answers
  • 00:19 --> 00:21features the latest information on
  • 00:21 --> 00:23cancer care by welcoming oncologists and
  • 00:23 --> 00:25specialists who are on the forefront of
  • 00:25 --> 00:27the battle to fight cancer. This week,
  • 00:27 --> 00:29it's a conversation about cancer care
  • 00:29 --> 00:31in the community with Doctor Anamika Katoch.
  • 00:31 --> 00:34Dr Katoch is assistant professor
  • 00:34 --> 00:35of clinical medicine and medical
  • 00:35 --> 00:38oncology at the Yale School of Medicine,
  • 00:38 --> 00:41where Doctor Chagpar is a
  • 00:41 --> 00:43professor of surgical oncology.
  • 00:43 --> 00:46Doctor Katoch, maybe you could start off by
  • 00:46 --> 00:49telling us a little bit about yourself and
  • 00:49 --> 00:51what it is that you do.
  • 00:51 --> 00:53So I'm a hematologist oncologist,
  • 00:53 --> 00:56and I work out of Smilow Waterbury.
  • 00:56 --> 00:58It's a small community setting we
  • 00:58 --> 01:01work out of a regional Cancer Center
  • 01:01 --> 01:04called the Harold Leever Cancer Center.
  • 01:04 --> 01:06So I'm a general community oncologist,
  • 01:06 --> 01:09and I see all kinds of cancer.
  • 01:09 --> 01:11The more common cancers,
  • 01:11 --> 01:13of course, are more common,
  • 01:13 --> 01:17so I tend to see those more than the others.
  • 01:17 --> 01:20But breast, lung, colon, lymphoma,
  • 01:20 --> 01:22and also some hematology patients.
  • 01:22 --> 01:26And so how common is cancer in
  • 01:26 --> 01:27the community?
  • 01:27 --> 01:30I mean when we think about
  • 01:30 --> 01:32cancers,
  • 01:32 --> 01:34very often we think about
  • 01:34 --> 01:37people going to large centers.
  • 01:37 --> 01:38New York, Boston,
  • 01:38 --> 01:40Houston, New Haven.
  • 01:40 --> 01:42But you're in a
  • 01:42 --> 01:43small Community Center.
  • 01:43 --> 01:46So how often does cancer present
  • 01:46 --> 01:48in those community centers?
  • 01:48 --> 01:50So it is surprising
  • 01:50 --> 01:54to see that cancer is very prevalent,
  • 01:54 --> 01:56and especially in the Waterbury area.
  • 01:56 --> 01:59I would say maybe because it
  • 01:59 --> 02:02has been an industrial town.
  • 02:02 --> 02:06And we do tend to see a lot of breast cancer.
  • 02:06 --> 02:10A lot of bladder cancer in this area as well.
  • 02:10 --> 02:12And yes,
  • 02:12 --> 02:14the bigger centers actually have
  • 02:14 --> 02:17the good fortune of having many
  • 02:17 --> 02:19good bigger centers around us.
  • 02:19 --> 02:21There's Memorial Sloan,
  • 02:21 --> 02:22Dana Farber.
  • 02:22 --> 02:25And certainly these are very useful and
  • 02:25 --> 02:28helpful for us when we have particularly
  • 02:28 --> 02:31tough situations where we need to
  • 02:31 --> 02:33get another opinion or some help.
  • 02:33 --> 02:37But I would say in the general Community,
  • 02:37 --> 02:38cancer is fairly
  • 02:38 --> 02:41prevalent and so many people,
  • 02:41 --> 02:44because cancer really doesn't discriminate
  • 02:44 --> 02:47based on where you live
  • 02:47 --> 02:50and many people may wonder,
  • 02:50 --> 02:53are there advantages and disadvantages
  • 02:53 --> 02:55to being treated closer to home
  • 02:55 --> 02:58versus going into a larger center?
  • 02:58 --> 03:00What would you say to people
  • 03:00 --> 03:02who are contemplating those
  • 03:02 --> 03:04decisions?
  • 03:06 --> 03:09It is important,
  • 03:09 --> 03:11especially for certain rare cancers
  • 03:11 --> 03:15to be seen at bigger centers that tend
  • 03:15 --> 03:18to see a lot more of those cancers.
  • 03:18 --> 03:20Sarcomas being one.
  • 03:20 --> 03:22They require a real multi
  • 03:22 --> 03:23disciplinary approach.
  • 03:23 --> 03:26You have to have surgeons who've
  • 03:26 --> 03:28done enough of those surgeries,
  • 03:28 --> 03:31trained radiation oncology team,
  • 03:31 --> 03:33trained chemotherapy
  • 03:33 --> 03:35professionals who've dealt
  • 03:35 --> 03:37enough of with that cancer.
  • 03:37 --> 03:39It is always patients preference
  • 03:39 --> 03:41to be treated close to home and
  • 03:41 --> 03:44nobody wants to drive 2 hours to get
  • 03:44 --> 03:46treatment because you know chemotherapy
  • 03:46 --> 03:48treatment is not just about chemotherapy,
  • 03:48 --> 03:50it's also about supportive
  • 03:50 --> 03:51care that goes with it.
  • 03:51 --> 03:53So we don't just see patients
  • 03:53 --> 03:55on day one and say OK,
  • 03:55 --> 03:58now we'll see you in three weeks.
  • 03:58 --> 03:59It doesn't work like that.
  • 03:59 --> 04:02So we see patients on day one,
  • 04:02 --> 04:04we're always available by phone.
  • 04:04 --> 04:06We are seeing them sometimes the very
  • 04:06 --> 04:08next day, sometimes within a week.
  • 04:08 --> 04:10Sometimes they need transfusion support.
  • 04:10 --> 04:11So it is a
  • 04:11 --> 04:14complicated and complex process,
  • 04:14 --> 04:16so patients preference is always
  • 04:16 --> 04:20to be treated in your home and I
  • 04:20 --> 04:22would say that we have very robust
  • 04:22 --> 04:24multidisciplinary teams for almost
  • 04:24 --> 04:27all cancers and we also recognize that
  • 04:27 --> 04:30some cancers do better when they are
  • 04:30 --> 04:32referred out to tertiary centers,
  • 04:32 --> 04:34one major example being acute leukemia.
  • 04:36 --> 04:39It is a cancer that requires
  • 04:39 --> 04:40a lot of resources.
  • 04:40 --> 04:41A lot of support,
  • 04:41 --> 04:44a lot of experience and
  • 04:44 --> 04:45people who have acute leukemias
  • 04:45 --> 04:48tend to do better when they're
  • 04:48 --> 04:50treated at tertiary care centers,
  • 04:50 --> 04:52so this is also recognizing
  • 04:52 --> 04:54what are your limitations.
  • 04:54 --> 04:56And what are the patients that
  • 04:56 --> 04:58you can best serve and which
  • 04:58 --> 05:01patients will do better if they are
  • 05:01 --> 05:04referred out? And so I guess the
  • 05:04 --> 05:07take home message there is that if
  • 05:07 --> 05:10a patient has a cancer that they can
  • 05:10 --> 05:13be seen at a Cancer Center in their
  • 05:13 --> 05:15community and that Community Center
  • 05:15 --> 05:17will have no hesitation about referring
  • 05:17 --> 05:19them out to a larger center if that's
  • 05:19 --> 05:21in the patients best interest.
  • 05:21 --> 05:24That is absolutely correct and a
  • 05:24 --> 05:26lot of times it is driven by physicians.
  • 05:26 --> 05:28Sometimes it's driven by patients,
  • 05:28 --> 05:30but I have to say that patients
  • 05:30 --> 05:31often feel uncomfortable telling
  • 05:31 --> 05:33their physicians that they
  • 05:33 --> 05:36want to get a second opinion and
  • 05:36 --> 05:38part of it will also depend upon
  • 05:38 --> 05:40your approach to the patient,
  • 05:40 --> 05:43and we're sort of very open about it.
  • 05:43 --> 05:44We understand
  • 05:44 --> 05:45that this is cancer.
  • 05:45 --> 05:48It can be a life changing diagnosis.
  • 05:48 --> 05:51So we we will often say to our patients,
  • 05:51 --> 05:53if you would like another opinion,
  • 05:53 --> 05:55please let me know
  • 05:55 --> 05:57and I will help you get one.
  • 05:57 --> 06:00So sometimes people do elect to get
  • 06:00 --> 06:01another opinion and lots of times
  • 06:01 --> 06:03people say no,
  • 06:03 --> 06:05what you're saying makes sense if
  • 06:05 --> 06:07they've already developed a
  • 06:07 --> 06:10sense of trust and confidence in you
  • 06:10 --> 06:12they will stay with you
  • 06:12 --> 06:14and be treated close to where they
  • 06:14 --> 06:17live and so are there particular
  • 06:17 --> 06:18cancers that are particularly amenable
  • 06:18 --> 06:20to being treated closer to home.
  • 06:20 --> 06:23So you mentioned that the rare cancers
  • 06:23 --> 06:26might be ones where you want to seek
  • 06:26 --> 06:28a second opinion, but are there
  • 06:28 --> 06:30certain cancers that
  • 06:30 --> 06:33you think, if you have
  • 06:33 --> 06:35for example, breast cancer or colon
  • 06:35 --> 06:38cancer that that those really can
  • 06:38 --> 06:40be treated closer to where you
  • 06:40 --> 06:42live that you don't necessarily
  • 06:42 --> 06:44need to go to a larger center.
  • 06:45 --> 06:47That is absolutely true.
  • 06:47 --> 06:49It of course depends upon
  • 06:49 --> 06:51the strength of your surgical
  • 06:51 --> 06:53staff and your surgical support,
  • 06:53 --> 06:55because a lot of these
  • 06:55 --> 06:57cancers do need surgery.
  • 06:57 --> 06:59So if you have a trained
  • 06:59 --> 07:02oncological surgeon on staff who
  • 07:02 --> 07:05is equipped to do these surgeries,
  • 07:05 --> 07:07then I think these cancers can
  • 07:07 --> 07:10be very well handled in the community.
  • 07:11 --> 07:13And what questions should
  • 07:13 --> 07:15patients be asking of their
  • 07:15 --> 07:17team of doctors if they are
  • 07:17 --> 07:19seen by a Community cancer program,
  • 07:19 --> 07:21what questions should they be asking in
  • 07:21 --> 07:24order to make the best informed decision
  • 07:24 --> 07:26as to where they should be treated?
  • 07:27 --> 07:29That's a good question,
  • 07:29 --> 07:31but can be a little bit tricky.
  • 07:31 --> 07:33I don't know if patients
  • 07:33 --> 07:35would entirely feel comfortable
  • 07:35 --> 07:36sometimes asking their physicians
  • 07:36 --> 07:38what their experiences
  • 07:38 --> 07:39in treating this cancer are.
  • 07:39 --> 07:41And I do get that question,
  • 07:42 --> 07:42but very occasionally,
  • 07:42 --> 07:45but I think it is important for
  • 07:45 --> 07:47patients to get involved in their
  • 07:47 --> 07:49care and ask these questions,
  • 07:49 --> 07:52and I think a lot of times people don't
  • 07:52 --> 07:54ask this question because they feel that
  • 07:54 --> 07:57they are going to offend the physician.
  • 07:57 --> 08:00Which sometimes may be true,
  • 08:00 --> 08:03but most times is not.
  • 08:03 --> 08:05So I think it's fair enough
  • 08:05 --> 08:07to say, Doctor,
  • 08:07 --> 08:10do you treat a lot of these cancers and
  • 08:10 --> 08:13it's sort of a ubiquitous question.
  • 08:15 --> 08:17How do patients generally do?
  • 08:17 --> 08:19Do you think I need a second opinion?
  • 08:19 --> 08:22So I think these are all fair
  • 08:22 --> 08:24questions to ask and say,
  • 08:24 --> 08:26do you work with the surgeon closely?
  • 08:26 --> 08:29Do you know if he's done many surgeries?
  • 08:29 --> 08:31Is it possible for me to speak
  • 08:31 --> 08:33to someone who has
  • 08:33 --> 08:35gone through this process?
  • 08:35 --> 08:39Also, just basic questions that might help
  • 08:39 --> 08:41keep patients well informed.
  • 08:41 --> 08:44And I think that that's so important
  • 08:44 --> 08:46that patients really do advocate
  • 08:46 --> 08:49for themselves and truthfully,
  • 08:49 --> 08:51many Community programs actually
  • 08:51 --> 08:54do have the infrastructure to be
  • 08:54 --> 08:56able to provide good quality care
  • 08:56 --> 08:59for the more common cancers.
  • 08:59 --> 09:01So you mentioned, for example,
  • 09:01 --> 09:03that you have a multidisciplinary
  • 09:03 --> 09:06team tell us more about how
  • 09:06 --> 09:08that works in the Community
  • 09:08 --> 09:09setting?
  • 09:09 --> 09:12I would say that our our care,
  • 09:12 --> 09:14even if I say so myself,
  • 09:16 --> 09:18We bring most of our cases to a
  • 09:18 --> 09:19multidisciplinary tumor conference.
  • 09:19 --> 09:21So if I were to pick, let's say,
  • 09:21 --> 09:24the most common cancer that we see in women,
  • 09:24 --> 09:27which is breast cancer.
  • 09:27 --> 09:31So once a woman gets a mammogram,
  • 09:31 --> 09:34gets a biopsy, or sees a surgeon,
  • 09:34 --> 09:37she is presented at a
  • 09:37 --> 09:39multidisciplinary tumor conference.
  • 09:40 --> 09:44For people who don't know what that is,
  • 09:44 --> 09:46it is basically a collection
  • 09:46 --> 09:49of many oncologists or any
  • 09:49 --> 09:51oncologists in the community.
  • 09:51 --> 09:54Radiation oncology, radiology, the breast
  • 09:54 --> 09:55surgeons themselves,
  • 09:55 --> 09:57social worker, nutritionists.
  • 09:57 --> 10:00So we all get together as a team
  • 10:00 --> 10:02and discuss the presentation of
  • 10:02 --> 10:05each sort of person's cancer,
  • 10:05 --> 10:08and then we decide
  • 10:11 --> 10:13to dealing with that situation.
  • 10:13 --> 10:16Being most of the time, it's standard,
  • 10:16 --> 10:18but things are changing.
  • 10:18 --> 10:21You know we were used to using,
  • 10:21 --> 10:22for example,
  • 10:22 --> 10:24chemotherapy in always the
  • 10:24 --> 10:25post surgical setting.
  • 10:25 --> 10:28But now we're moving to using
  • 10:28 --> 10:29treatment sometimes upfront
  • 10:29 --> 10:31before surgery so not everybody
  • 10:31 --> 10:34is a good candidate for that.
  • 10:34 --> 10:36We talk about
  • 10:36 --> 10:38the things like that.
  • 10:38 --> 10:41Other things that come up are genetics.
  • 10:41 --> 10:43This has also become a very
  • 10:43 --> 10:46important part of management for patients.
  • 10:46 --> 10:49You know 10% of the cancers
  • 10:49 --> 10:50that are diagnosed,
  • 10:50 --> 10:52especially breast cancer I'm
  • 10:52 --> 10:54talking about can be genetic,
  • 10:54 --> 10:56so we always talk about that.
  • 10:56 --> 10:58We have a genetic counselor
  • 10:58 --> 11:01as a part of the team who will
  • 11:01 --> 11:03be there and say, OK,
  • 11:03 --> 11:05I think this person needs to meet with me.
  • 11:05 --> 11:06We need to
  • 11:06 --> 11:09check her or family members.
  • 11:09 --> 11:12If there are
  • 11:12 --> 11:13financial issues.
  • 11:13 --> 11:14Social issues.
  • 11:14 --> 11:16We have a social worker who is
  • 11:16 --> 11:20present who can help
  • 11:20 --> 11:22guide patients through that process.
  • 11:22 --> 11:25We have a licensed nutritionist who can
  • 11:25 --> 11:27provide support as to healthy diets.
  • 11:27 --> 11:30Because this really becomes a very
  • 11:30 --> 11:32important part of what people feel
  • 11:32 --> 11:35that they have some control over it
  • 11:35 --> 11:37and it empowers them.
  • 11:37 --> 11:40And of course we know that obesity
  • 11:40 --> 11:43and cancer have a direct link so
  • 11:43 --> 11:46we always want to talk about
  • 11:46 --> 11:48maintaining a healthy lifestyle
  • 11:48 --> 11:50and a healthy body mass index.
  • 11:50 --> 11:53Once a case is discussed at
  • 11:53 --> 11:55the Multidisciplinary conference,
  • 11:55 --> 11:57we will then make recommendations.
  • 11:57 --> 12:00The patient gets established with
  • 12:00 --> 12:02medical oncologist or radiation oncologist,
  • 12:02 --> 12:06and it's really a very good
  • 12:06 --> 12:07collaborative approach.
  • 12:08 --> 12:10The other thing that we often
  • 12:10 --> 12:13talk about on the show is things like
  • 12:13 --> 12:15personalized medicine and genomics.
  • 12:15 --> 12:17So are those things available in
  • 12:17 --> 12:19Community settings or are those
  • 12:19 --> 12:21really only the purview of the
  • 12:21 --> 12:23larger academic centers?
  • 12:23 --> 12:26There has been so much progress in
  • 12:26 --> 12:29these things that they are now
  • 12:29 --> 12:32easily available to us as well.
  • 12:32 --> 12:36Our goal is always to be able to
  • 12:36 --> 12:40at least offer standard a standard of care,
  • 12:40 --> 12:43which means if you were to see
  • 12:43 --> 12:47an oncologist here or you went to the
  • 12:47 --> 12:50West Coast and used an oncologist there,
  • 12:50 --> 12:52the therapy recommended
  • 12:52 --> 12:55would be similar,
  • 12:55 --> 12:57if not identical,
  • 12:57 --> 13:00so that is called standardized
  • 13:00 --> 13:02care and it is based now
  • 13:02 --> 13:05on genomics, which do play a huge role
  • 13:05 --> 13:07in determining treatment for cancer,
  • 13:07 --> 13:09it has been a significant advance.
  • 13:11 --> 13:13In the treatment of breast cancer,
  • 13:13 --> 13:15when we look back we find that
  • 13:15 --> 13:18we were probably over treating a lot of
  • 13:18 --> 13:21the breast cancer patients with chemotherapy.
  • 13:21 --> 13:24Now we have tests that can actually
  • 13:24 --> 13:26determine benefit from chemotherapy,
  • 13:26 --> 13:28and these are based on genomic
  • 13:28 --> 13:31tests allowed for a lot of the
  • 13:31 --> 13:32cancers including lung cancer,
  • 13:32 --> 13:34colon cancer we are doing
  • 13:34 --> 13:36molecular testing we're
  • 13:36 --> 13:38identifying targets on these cells,
  • 13:38 --> 13:41which we know drive the growth
  • 13:41 --> 13:43of cancer cells,
  • 13:43 --> 13:46and then we can actually pick
  • 13:46 --> 13:48medications that would specifically
  • 13:48 --> 13:50block these drivers and that
  • 13:51 --> 13:54is sort of the tailor made approach
  • 13:54 --> 13:56for treating cancer.
  • 13:56 --> 13:58So it sounds like
  • 13:58 --> 14:00you know patients can get that
  • 14:00 --> 14:04same kind of genomic testing in
  • 14:04 --> 14:06that personalized therapies
  • 14:06 --> 14:08even staying closer to home.
  • 14:08 --> 14:10We're going to take a short break
  • 14:10 --> 14:13for a medical minute and come
  • 14:13 --> 14:16back and talk more about cancer
  • 14:16 --> 14:18care in the community with my
  • 14:18 --> 14:20guest Doctor Katoch.
  • 14:20 --> 14:23Support for Yale Cancer Answers comes from
  • 14:23 --> 14:25AstraZeneca, working to eliminate
  • 14:25 --> 14:27cancer as a cause of death.
  • 14:27 --> 14:31Learn more at astrazeneca-us.com.
  • 14:31 --> 14:33This is a medical minute
  • 14:33 --> 14:34about colorectal cancer.
  • 14:34 --> 14:35When detected early,
  • 14:35 --> 14:38colorectal cancer is easily treated
  • 14:38 --> 14:41and highly curable and as a result
  • 14:41 --> 14:43it's recommended that men and women
  • 14:43 --> 14:46over the age of 45 have regular
  • 14:46 --> 14:48colonoscopies to screen for the disease.
  • 14:48 --> 14:50Tumor gene analysis has helped
  • 14:50 --> 14:52improve management of colorectal
  • 14:52 --> 14:54cancer by identifying the patients
  • 14:54 --> 14:56most likely to benefit from
  • 14:56 --> 14:58chemotherapy and newer targeted agents,
  • 14:58 --> 15:00resulting in more patient
  • 15:00 --> 15:01specific treatments.
  • 15:01 --> 15:03More information is available
  • 15:03 --> 15:04at yalecancercenter.org.
  • 15:04 --> 15:07You're listening to Connecticut Public Radio.
  • 15:10 --> 15:12Welcome back to Yale Cancer Answers.
  • 15:12 --> 15:15We're discussing the care of
  • 15:15 --> 15:17cancer patients in the community
  • 15:17 --> 15:20and right before the break
  • 15:20 --> 15:22we were talking about some of the
  • 15:22 --> 15:25differences and the other thing that I
  • 15:25 --> 15:27was wondering about was clinical trials.
  • 15:27 --> 15:30So often on this show,
  • 15:30 --> 15:33we talk about the importance of
  • 15:33 --> 15:35clinical trials and how that's
  • 15:35 --> 15:38one of the ways to get tomorrow's
  • 15:38 --> 15:40therapies today in that patients
  • 15:40 --> 15:43often will get the best care by
  • 15:43 --> 15:45participating in clinical trials for
  • 15:45 --> 15:47which they are eligible and for which
  • 15:47 --> 15:50their Doctor thinks they would benefit from.
  • 15:50 --> 15:53Talk to us about whether clinical
  • 15:53 --> 15:55trials are available in the community setting.
  • 15:55 --> 15:59You bring up a great point,
  • 15:59 --> 16:02and it is true that we wouldn't
  • 16:02 --> 16:05be where we are today in cancer if
  • 16:05 --> 16:08we didn't encourage our patients
  • 16:08 --> 16:10to participate in clinical trials.
  • 16:10 --> 16:13As everyone knows, 2020 has
  • 16:13 --> 16:15been a particularly challenging year,
  • 16:15 --> 16:18and also for clinical trials it has been a very
  • 16:18 --> 16:20challenging year simply because
  • 16:20 --> 16:21clinical trials require
  • 16:21 --> 16:22very diligent follow-up,
  • 16:22 --> 16:24mostly for patient safety,
  • 16:24 --> 16:27and that we all know because of covid
  • 16:27 --> 16:29we've had to resort to
  • 16:29 --> 16:31virtual appointments and seeing
  • 16:31 --> 16:34patients may be a little bit
  • 16:34 --> 16:36less frequently than we normally would,
  • 16:36 --> 16:39so a lot of the clinical trials
  • 16:39 --> 16:40had to be put
  • 16:40 --> 16:44on hold, but usually we have a very
  • 16:44 --> 16:46robust collection of clinical trials
  • 16:46 --> 16:48for patients with breast cancer,
  • 16:48 --> 16:50colon, cancer, lung cancer,
  • 16:50 --> 16:51chronic leukemias,
  • 16:51 --> 16:52and myelomas.
  • 16:52 --> 16:54That brings up
  • 16:54 --> 16:57a great point. The fact that you're
  • 16:57 --> 17:00part of a network and can avail
  • 17:00 --> 17:02yourself of clinical trials that
  • 17:02 --> 17:05are available at larger centers.
  • 17:05 --> 17:08Maybe not all of the trials,
  • 17:08 --> 17:11but certainly a collaboration whereby
  • 17:11 --> 17:13patients can avail themselves
  • 17:13 --> 17:14of clinical trials,
  • 17:14 --> 17:17oftentimes closer to home, and if not,
  • 17:17 --> 17:20you can always send them to to a larger
  • 17:20 --> 17:22center where they can participate
  • 17:22 --> 17:25and that brings up my next question,
  • 17:25 --> 17:28which is in those cases where
  • 17:28 --> 17:32there is a particular nuances of the care
  • 17:32 --> 17:35or where a second opinion might be needed,
  • 17:35 --> 17:38is it possible for patients to
  • 17:38 --> 17:40seek a second opinion somewhere
  • 17:40 --> 17:42and still get treated
  • 17:42 --> 17:43closer to home?
  • 17:43 --> 17:46So for example getting the
  • 17:46 --> 17:49advice of an oncologist closer to home
  • 17:49 --> 17:52about what particular regimen to use,
  • 17:52 --> 17:55or how a radiation plan might be structured,
  • 17:55 --> 17:58but then still get their care closer to home?
  • 17:58 --> 18:00Absolutely yes,
  • 18:00 --> 18:03and this happens more
  • 18:03 --> 18:05frequently than one would think.
  • 18:05 --> 18:08And you know, sometimes I'll say to my
  • 18:08 --> 18:10patients when I'm torn between two options.
  • 18:10 --> 18:13And I'll say I would like you to see,
  • 18:15 --> 18:17so and so maybe at the Dana Farber Institute,
  • 18:17 --> 18:19maybe closer to home at Smilow.
  • 18:19 --> 18:21And then I always give them the
  • 18:21 --> 18:24option that if this is
  • 18:26 --> 18:28recommended and if it's not on a clinical
  • 18:28 --> 18:31trial and we are able to do it here,
  • 18:31 --> 18:33you are welcome to come here and
  • 18:33 --> 18:36we would love to treat you here
  • 18:36 --> 18:37if that is your preference,
  • 18:37 --> 18:38so this is,
  • 18:38 --> 18:40you know a very sort of open
  • 18:40 --> 18:42discussion with patients,
  • 18:42 --> 18:44and sometimes patients will finish
  • 18:44 --> 18:46their clinical trial and then will
  • 18:46 --> 18:48continue to follow with you as their
  • 18:48 --> 18:50primary oncologist.
  • 18:50 --> 18:52Ultimately it's about the patient.
  • 18:52 --> 18:54What is best for the patient,
  • 18:54 --> 18:57and I make sure that our patients
  • 18:58 --> 19:00know that and they're not feeling pressured
  • 19:00 --> 19:02and not feeling that their
  • 19:02 --> 19:03offending us in any way.
  • 19:03 --> 19:05It's important
  • 19:05 --> 19:07for patients and everybody listening
  • 19:07 --> 19:08to really understand that.
  • 19:08 --> 19:11You know this is a collaboration
  • 19:11 --> 19:12and it's a collaboration amongst
  • 19:12 --> 19:15physicians who are all trying to
  • 19:15 --> 19:17treat you in the best possible way.
  • 19:17 --> 19:20And so you're not going to offend
  • 19:20 --> 19:23anybody and for for the most part
  • 19:23 --> 19:25many of us actually do seek the opinions
  • 19:25 --> 19:28of our colleagues at multidisciplinary
  • 19:28 --> 19:30tumor conferences like you mentioned,
  • 19:30 --> 19:32as well as outside the institution
  • 19:32 --> 19:35and frequently you can get the
  • 19:35 --> 19:37same care then closer to home.
  • 19:37 --> 19:39If somebody has a better idea
  • 19:39 --> 19:42of how to treat something.
  • 19:42 --> 19:44Whereby those services
  • 19:44 --> 19:46are available in the community.
  • 19:46 --> 19:48You can still do so.
  • 19:48 --> 19:51Talk to me a little bit
  • 19:51 --> 19:53about kind of community support.
  • 19:53 --> 19:57You mentioned one of the
  • 19:57 --> 19:58disadvantages sometimes of going
  • 19:58 --> 20:01into a larger center is that you
  • 20:01 --> 20:04know frequently if care is required,
  • 20:04 --> 20:06say for example with radiation therapy,
  • 20:06 --> 20:09five days a week for many weeks
  • 20:09 --> 20:13that a 2 hour drive might not be
  • 20:14 --> 20:16the most feasible thing one would
  • 20:16 --> 20:19also imagine that just being
  • 20:19 --> 20:21in the community where you're at,
  • 20:21 --> 20:23being around loved ones and so
  • 20:23 --> 20:26on can sometimes be a little bit
  • 20:26 --> 20:27more comfortable for
  • 20:27 --> 20:30patients. Do you find that that's the case?
  • 20:30 --> 20:32So I would say that in cancer care
  • 20:32 --> 20:34that is of utmost importance.
  • 20:34 --> 20:37This is 1 diagnosis where
  • 20:37 --> 20:39just having the support of the
  • 20:39 --> 20:42people you love is so meaningful
  • 20:42 --> 20:44because it's not just a physical
  • 20:44 --> 20:46diagnosis. It's an emotional,
  • 20:46 --> 20:49psychological diagnosis that
  • 20:49 --> 20:51affects all the people around you.
  • 20:51 --> 20:54So it's really important to have that social
  • 20:54 --> 20:57support not only from your family,
  • 20:57 --> 21:00but also from where you are being
  • 21:00 --> 21:02treated so where we are
  • 21:02 --> 21:04for example, at the Yale Cancer Center
  • 21:04 --> 21:07we have a radiation oncology division,
  • 21:07 --> 21:09which is in the same building.
  • 21:09 --> 21:11So people who need radiation
  • 21:11 --> 21:12can come right there.
  • 21:12 --> 21:15If we are doing something which is a
  • 21:15 --> 21:17combination chemotherapy and radiation,
  • 21:17 --> 21:18we will
  • 21:18 --> 21:20try to make sure
  • 21:20 --> 21:22that their appointments
  • 21:22 --> 21:23can be coordinated that life really
  • 21:23 --> 21:26can be as simple as possible for them.
  • 21:26 --> 21:28Sometimes people don't have transport,
  • 21:28 --> 21:30so we have a social worker on site who will
  • 21:30 --> 21:33arrange for transport for people and
  • 21:34 --> 21:36we will tell our patients, our elderly
  • 21:36 --> 21:38patients who often rely on their childrenm
  • 21:39 --> 21:40but their children work,
  • 21:40 --> 21:42so it's not always possible for
  • 21:42 --> 21:44somebody to give you a ride each
  • 21:44 --> 21:46and every day back and forth.
  • 21:46 --> 21:48So we have that kind of support and
  • 21:48 --> 21:51we want our patients to know about it.
  • 21:51 --> 21:54We want them to use it.
  • 21:54 --> 21:56We also have support groups.
  • 21:56 --> 21:59We have a very robust and active
  • 21:59 --> 22:00breast Cancer Support group.
  • 22:00 --> 22:02Other support groups which are
  • 22:02 --> 22:05not as robust but are present.
  • 22:05 --> 22:08They meet once a month I think now
  • 22:08 --> 22:11with some of them have been
  • 22:11 --> 22:13meeting remotely but that women
  • 22:13 --> 22:16also find a very strong sense
  • 22:16 --> 22:18of community and support with
  • 22:18 --> 22:20those centers and I would
  • 22:20 --> 22:22think that the other
  • 22:22 --> 22:24place where
  • 22:24 --> 22:28optimizing and kind of using
  • 22:28 --> 22:31that social support is at end of life.
  • 22:31 --> 22:34In terms of palliative care.
  • 22:34 --> 22:37So our palliative care resource is
  • 22:37 --> 22:40available in the Community both on
  • 22:40 --> 22:42inpatient as well as there is
  • 22:42 --> 22:45such a thing as home palliative care
  • 22:45 --> 22:48where people can really
  • 22:48 --> 22:51take community all the way back to
  • 22:51 --> 22:55your own home and have the services
  • 22:55 --> 22:56that keep you comfortable at
  • 22:56 --> 22:58the end of life at home.
  • 22:59 --> 23:02You bring up an excellent,
  • 23:02 --> 23:05excellent question, so valuative care is
  • 23:05 --> 23:08a very important part of cancer care,
  • 23:08 --> 23:11and you know it includes pain control.
  • 23:11 --> 23:13It includes things that can
  • 23:13 --> 23:16occur like loss of appetite,
  • 23:16 --> 23:18loss of interest in life,
  • 23:18 --> 23:21so we actually offer a consultative
  • 23:21 --> 23:24service that is available through Yale.
  • 23:24 --> 23:27We can do it either virtually
  • 23:27 --> 23:29or we can do it
  • 23:29 --> 23:33in the office, we actually have consultative
  • 23:33 --> 23:35care services available on site,
  • 23:35 --> 23:39so that is outpatient and inpatient.
  • 23:39 --> 23:41Palliative care services are available
  • 23:41 --> 23:42through both hospitals.
  • 23:42 --> 23:46So both Waterbury Hospital and Saint
  • 23:46 --> 23:48Mary's Hospital offer palliative
  • 23:48 --> 23:51care services is an inpatient unit 4.
  • 23:53 --> 23:56A lot of patients want to be home.
  • 23:56 --> 23:58They want to
  • 23:58 --> 24:00be surrounded with the loved ones they
  • 24:00 --> 24:03want to be in familiar surroundings.
  • 24:03 --> 24:05So we have several Hospice agencies,
  • 24:07 --> 24:09who can make that possible
  • 24:09 --> 24:13and who do really do a very
  • 24:13 --> 24:16fabulous job of taking
  • 24:16 --> 24:19care of patients at the end of
  • 24:19 --> 24:21life, they trained to do that.
  • 24:21 --> 24:23They are compassionate,
  • 24:23 --> 24:25their empathetic and most patients
  • 24:25 --> 24:27are very pleased with their services.
  • 24:29 --> 24:31It's really important for cancer
  • 24:31 --> 24:33patients to get treated where
  • 24:33 --> 24:36they feel the most comfortable and
  • 24:36 --> 24:38being surrounded by loved ones,
  • 24:38 --> 24:41particularly at the end of life,
  • 24:41 --> 24:44is something that they may consider.
  • 24:47 --> 24:50You've mentioned a few times
  • 24:50 --> 24:52this whole crisis that
  • 24:52 --> 24:54we've been through with Covid,
  • 24:54 --> 24:58which in and of itself has restricted
  • 24:58 --> 25:00mobility in terms of going across
  • 25:00 --> 25:03state lines for certain states,
  • 25:03 --> 25:05travel and so on.
  • 25:05 --> 25:08Talk to us a little bit about
  • 25:08 --> 25:10how the covid epidemic affected
  • 25:10 --> 25:13cancer care in the community.
  • 25:14 --> 25:18Well, you know a lot of the screening
  • 25:18 --> 25:21procedures that people would go for,
  • 25:21 --> 25:23I think those have been the
  • 25:23 --> 25:27first ones to have gone
  • 25:27 --> 25:29away or have been put on hold.
  • 25:29 --> 25:31So screening mammograms,
  • 25:31 --> 25:32screening colonoscopies,
  • 25:32 --> 25:34those have been a challenge,
  • 25:34 --> 25:37so people have either put them off
  • 25:37 --> 25:41or have just been afraid to go out.
  • 25:41 --> 25:42And you know,
  • 25:42 --> 25:45we've resorted to some virtual visits.
  • 25:45 --> 25:46Which I would say patients are
  • 25:46 --> 25:48thankful that they're seeing a doctor,
  • 25:48 --> 25:50even if they're not coming into
  • 25:50 --> 25:52the office and patients who have
  • 25:52 --> 25:54been able to come to the office
  • 25:54 --> 25:56are just so delighted to be there,
  • 25:56 --> 25:58and they have often said to me
  • 25:58 --> 26:00that this is my first
  • 26:00 --> 26:02outing in the last three months.
  • 26:02 --> 26:05I cannot tell you how happy I am to be here,
  • 26:05 --> 26:10so it's sort of kind of funny to hear that.
  • 26:13 --> 26:16But a lot of people have delayed their
  • 26:16 --> 26:20care and we are beginning to see
  • 26:20 --> 26:22a little bit of an uptick
  • 26:22 --> 26:25now in patients presenting with slightly
  • 26:25 --> 26:27advanced cancers at this time because
  • 26:27 --> 26:30of the lack of screening, you
  • 26:30 --> 26:33think lack of screening and self delayed
  • 26:33 --> 26:35patient care, obviously,
  • 26:35 --> 26:38for reasons that are understandable.
  • 26:39 --> 26:41And so are you recommending that
  • 26:41 --> 26:44people get back into screening now?
  • 26:44 --> 26:47Do you think that we have gotten over
  • 26:47 --> 26:49the height of the pandemic such
  • 26:49 --> 26:53that people should really get back into
  • 26:53 --> 26:55doing those screening mammograms and
  • 26:55 --> 26:56colonoscopies?
  • 26:56 --> 26:58I think in the Community
  • 26:58 --> 27:00people are already back to it.
  • 27:00 --> 27:03You know our centers, they are
  • 27:03 --> 27:05asking everybody
  • 27:05 --> 27:07to wear masks, temperature checks.
  • 27:07 --> 27:09Most people now have been immunized.
  • 27:09 --> 27:11I would say at least 90%
  • 27:11 --> 27:13of my patient population,
  • 27:13 --> 27:16who I ask has either received the
  • 27:16 --> 27:18vaccine or is going to receive
  • 27:18 --> 27:21it in the next few days so I do
  • 27:21 --> 27:24get a sense that at least as far
  • 27:24 --> 27:25as medical care is concerned,
  • 27:25 --> 27:28that the Community is getting back to normal.
  • 27:29 --> 27:32And do you think that some of the things
  • 27:32 --> 27:35that we've kind of learned about medicine
  • 27:35 --> 27:38and how medicine can be delivered?
  • 27:38 --> 27:41For example, you know virtual visits
  • 27:41 --> 27:42and telemedicine really opened up
  • 27:42 --> 27:46a whole horizon for people for
  • 27:46 --> 27:48whom transportation was a big issue.
  • 27:48 --> 27:51Do you think that that's here to stay?
  • 27:51 --> 27:53That will continue to have Tele
  • 27:53 --> 27:55medicine visits into the future?
  • 27:56 --> 27:57Excellent
  • 27:57 --> 27:59question and I think that it
  • 27:59 --> 28:02is here to stay and it has made
  • 28:02 --> 28:05life simpler for a lot of people.
  • 28:05 --> 28:07But it has also brought
  • 28:07 --> 28:08along many challenges.
  • 28:08 --> 28:10The older patients
  • 28:10 --> 28:12cannot get the video connection.
  • 28:12 --> 28:15They are so frustrated
  • 28:15 --> 28:18by the end of the visit.
  • 28:18 --> 28:20But I would say the telephone
  • 28:20 --> 28:22visits go much smoother,
  • 28:22 --> 28:25especially if you're dealing with
  • 28:25 --> 28:26an older population or you
  • 28:26 --> 28:28know people who are just not
  • 28:28 --> 28:30comfortable doing it on the phone.
  • 28:32 --> 28:33Other than the technology challenge,
  • 28:33 --> 28:36I think it is here to stay.
  • 28:36 --> 28:37Doctor Anamika Katoch is an
  • 28:37 --> 28:39assistant professor of clinical
  • 28:39 --> 28:40medicine and medical oncology
  • 28:40 --> 28:42at the Yale School of Medicine.
  • 28:42 --> 28:44If you have questions,
  • 28:44 --> 28:45the address is canceranswers@yale.edu
  • 28:45 --> 28:47and past editions of the program
  • 28:47 --> 28:49are available in audio and written
  • 28:49 --> 28:51form at yalecancercenter.org.
  • 28:51 --> 28:54We hope you'll join us next week to
  • 28:54 --> 28:57learn more about the fight against
  • 28:57 --> 29:00cancer here on Connecticut Public Radio.